Clinical Trial Update: Study of CM512 Injection in Subjects With Moderate-to-severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM512 Injection in subjects with moderate-to-severe asthma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CM512 Injection (CM512)

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Asthma | Phase 2 | Status: RECRUITING